Interleukin-2
13-281
Phase 1 small_molecule active
Quick answer
Interleukin-2 for Chronic Graft Versus Host Disease is a Phase 1 program (small_molecule) at IOVANCE BIOTHERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- IOVANCE BIOTHERAPEUTICS, INC.
- Indication
- Chronic Graft Versus Host Disease
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active